Steven V. Fox

1.9k total citations
28 papers, 997 citations indexed

About

Steven V. Fox is a scholar working on Cognitive Neuroscience, Endocrine and Autonomic Systems and Experimental and Cognitive Psychology. According to data from OpenAlex, Steven V. Fox has authored 28 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cognitive Neuroscience, 14 papers in Endocrine and Autonomic Systems and 13 papers in Experimental and Cognitive Psychology. Recurrent topics in Steven V. Fox's work include Sleep and Wakefulness Research (16 papers), Sleep and related disorders (13 papers) and Circadian rhythm and melatonin (13 papers). Steven V. Fox is often cited by papers focused on Sleep and Wakefulness Research (16 papers), Sleep and related disorders (13 papers) and Circadian rhythm and melatonin (13 papers). Steven V. Fox collaborates with scholars based in United States, Japan and Sierra Leone. Steven V. Fox's co-authors include Anthony L. Gotter, John J. Renger, Christopher J. Winrow, Paul J. Coleman, Pamela L. Tannenbaum, Susan L. Garson, Joanne Stevens, Scott M. Doran, C. Meacham Harrell and Duane R. Reiss and has published in prestigious journals such as Scientific Reports, Brain Research and Journal of Neurochemistry.

In The Last Decade

Steven V. Fox

27 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven V. Fox United States 16 724 603 597 167 156 28 997
Joanne Stevens United States 15 680 0.9× 577 1.0× 522 0.9× 121 0.7× 136 0.9× 20 960
Susan L. Garson United States 15 703 1.0× 602 1.0× 593 1.0× 87 0.5× 99 0.6× 19 850
Gabriël E. Jacobs Netherlands 16 230 0.3× 179 0.3× 136 0.2× 100 0.6× 130 0.8× 40 616
Michelle Baladi United States 16 215 0.3× 131 0.2× 286 0.5× 173 1.0× 349 2.2× 40 784
Jason L. Locke United States 11 293 0.4× 165 0.3× 259 0.4× 217 1.3× 372 2.4× 14 753
Sergio Melotto Italy 15 116 0.2× 59 0.1× 347 0.6× 255 1.5× 322 2.1× 21 871
Christoph Felder United States 11 266 0.4× 56 0.1× 78 0.1× 108 0.6× 337 2.2× 15 677
Hisao Nishikawa Japan 8 169 0.2× 115 0.2× 231 0.4× 85 0.5× 86 0.6× 9 514
JMA van Gerven Netherlands 11 168 0.2× 98 0.2× 106 0.2× 73 0.4× 178 1.1× 17 529

Countries citing papers authored by Steven V. Fox

Since Specialization
Citations

This map shows the geographic impact of Steven V. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven V. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven V. Fox more than expected).

Fields of papers citing papers by Steven V. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven V. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven V. Fox. The network helps show where Steven V. Fox may publish in the future.

Co-authorship network of co-authors of Steven V. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Steven V. Fox. A scholar is included among the top collaborators of Steven V. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven V. Fox. Steven V. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Raubertas, Richard F., Wendy Watson, Steven V. Fox, et al.. (2019). Decreased complexity of glucose dynamics in diabetes in rhesus monkeys. Scientific Reports. 9(1). 1438–1438. 1 indexed citations
3.
Raymond, Jennifer K., Mark W. Reid, Steven V. Fox, et al.. (2019). Adapting home telehealth group appointment model (CoYoT1 clinic) for a low SES, publicly insured, minority young adult population with type 1 diabetes. Contemporary Clinical Trials. 88. 105896–105896. 15 indexed citations
4.
Yao, Lihang, Andres D. Ramirez, Anthony J. Roecker, et al.. (2017). The dual orexin receptor antagonist, DORA‐22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine. Journal of Neurochemistry. 142(2). 204–214. 7 indexed citations
5.
Vardigan, Joshua D., Henry S. Lange, Spencer J. Tye, et al.. (2016). Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity. Psychopharmacology. 233(13). 2441–2450. 3 indexed citations
6.
Gotter, Anthony L., Mark S. Forman, C. Meacham Harrell, et al.. (2016). Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man. Scientific Reports. 6(1). 27147–27147. 67 indexed citations
7.
Roecker, Anthony J., Swati P. Mercer, Jeffrey M. Bergman, et al.. (2015). Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements. Bioorganic & Medicinal Chemistry Letters. 25(21). 4992–4999. 14 indexed citations
8.
Gotter, Anthony L., Susan L. Garson, Joanne Stevens, et al.. (2014). Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators. BMC Neuroscience. 15(1). 109–109. 40 indexed citations
9.
Tannenbaum, Pamela L., Joanne Stevens, Alan T. Savitz, et al.. (2014). Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs. Frontiers in Behavioral Neuroscience. 8. 182–182. 32 indexed citations
10.
Roecker, Anthony J., Swati P. Mercer, C. Meacham Harrell, et al.. (2014). Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis. Bioorganic & Medicinal Chemistry Letters. 24(9). 2079–2085. 9 indexed citations
11.
Raheem, Izzat T., Michael J. Breslin, Joseph G. Bruno, et al.. (2014). Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant. Bioorganic & Medicinal Chemistry Letters. 25(3). 444–450. 17 indexed citations
12.
Fox, Steven V., Anthony L. Gotter, Spencer J. Tye, et al.. (2013). Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats. Neuropsychopharmacology. 38(12). 2401–2408. 33 indexed citations
13.
Gotter, Anthony L., Christopher J. Winrow, Susan L. Garson, et al.. (2013). The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold. BMC Neuroscience. 14(1). 90–90. 76 indexed citations
14.
Ramirez, Andres D., Anthony L. Gotter, Steven V. Fox, et al.. (2013). Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators. Frontiers in Neuroscience. 7. 254–254. 33 indexed citations
15.
Gotter, Anthony L., Vincent P. Santarelli, Scott M. Doran, et al.. (2011). TASK-3 as a potential antidepressant target. Brain Research. 1416. 69–79. 35 indexed citations
16.
Winrow, Christopher J., Anthony L. Gotter, Christopher D. Cox, et al.. (2011). Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia. Neuropharmacology. 62(2). 978–987. 109 indexed citations
17.
Coburn, Craig A., Jiabing Wang, Richard Söll, et al.. (2011). Discovery of a Pharmacologically Active Antagonist of the Two‐Pore‐Domain Potassium Channel K2P9.1 (TASK‐3). ChemMedChem. 7(1). 123–133. 52 indexed citations
18.
Gotter, Anthony L., Joshua Millstein, Susan L. Garson, et al.. (2011). Pharmacological Validation of Candidate Causal Sleep Genes Identified in an N2 Cross. Journal of Neurogenetics. 25(4). 167–181. 7 indexed citations
19.
Kraus, Richard L., Yuxing Li, Anthony L. Gotter, et al.. (2010). In Vitro Characterization of T-Type Calcium Channel Antagonist TTA-A2 and In Vivo Effects on Arousal in Mice. Journal of Pharmacology and Experimental Therapeutics. 335(2). 409–417. 88 indexed citations
20.
Winrow, Christopher J., Keith Q. Tanis, Duane R. Reiss, et al.. (2009). Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology. 58(1). 185–194. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanne Stevens Breakdown of academic impact, for papers by Susan L. Garson Breakdown of academic impact, for papers by Gabriël E. Jacobs Breakdown of academic impact, for papers by Michelle Baladi Breakdown of academic impact, for papers by Jason L. Locke Breakdown of academic impact, for papers by Sergio Melotto Breakdown of academic impact, for papers by Christoph Felder Breakdown of academic impact, for papers by Hisao Nishikawa Breakdown of academic impact, for papers by JMA van Gerven
Rankless by CCL
2026